Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 28% ± 9% | |
lung | 11 studies | 32% ± 9% | |
intestine | 8 studies | 31% ± 13% | |
kidney | 7 studies | 27% ± 8% | |
eye | 7 studies | 33% ± 13% | |
brain | 6 studies | 27% ± 8% | |
lymph node | 5 studies | 30% ± 9% | |
pancreas | 4 studies | 46% ± 20% | |
bone marrow | 4 studies | 25% ± 10% | |
uterus | 4 studies | 37% ± 12% | |
breast | 4 studies | 26% ± 2% | |
liver | 4 studies | 30% ± 12% | |
prostate | 3 studies | 34% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4695.30 | 1445 / 1445 | 100% | 114.53 | 183 / 183 |
ovary | 100% | 7688.65 | 180 / 180 | 100% | 120.54 | 430 / 430 |
prostate | 100% | 5247.43 | 245 / 245 | 100% | 203.85 | 502 / 502 |
breast | 100% | 6254.14 | 459 / 459 | 100% | 165.57 | 1117 / 1118 |
lung | 100% | 5355.17 | 577 / 578 | 100% | 133.11 | 1154 / 1155 |
pancreas | 100% | 2572.89 | 327 / 328 | 100% | 144.50 | 178 / 178 |
thymus | 100% | 5251.49 | 653 / 653 | 100% | 179.36 | 603 / 605 |
brain | 100% | 4974.59 | 2633 / 2642 | 100% | 233.86 | 705 / 705 |
kidney | 100% | 4308.56 | 89 / 89 | 99% | 142.39 | 893 / 901 |
uterus | 100% | 6683.56 | 170 / 170 | 99% | 136.67 | 454 / 459 |
intestine | 100% | 5643.71 | 966 / 966 | 99% | 131.72 | 521 / 527 |
adrenal gland | 100% | 4735.57 | 258 / 258 | 99% | 189.17 | 227 / 230 |
bladder | 100% | 5157.52 | 21 / 21 | 98% | 124.04 | 496 / 504 |
stomach | 100% | 4012.04 | 359 / 359 | 98% | 107.33 | 281 / 286 |
liver | 100% | 2884.38 | 226 / 226 | 97% | 85.50 | 395 / 406 |
skin | 100% | 6133.66 | 1808 / 1809 | 95% | 134.75 | 449 / 472 |
adipose | 100% | 5991.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6100.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 187.36 | 29 / 29 |
muscle | 100% | 8773.34 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7516.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 128.80 | 45 / 45 |
heart | 99% | 5694.89 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 4879.89 | 887 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 97.87 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000296 | Biological process | spermine transport |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0045347 | Biological process | negative regulation of MHC class II biosynthetic process |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045344 | Biological process | negative regulation of MHC class I biosynthetic process |
GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006352 | Biological process | DNA-templated transcription initiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071339 | Cellular component | MLL1 complex |
GO_0005669 | Cellular component | transcription factor TFIID complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0033276 | Cellular component | transcription factor TFTC complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0001097 | Molecular function | TFIIH-class transcription factor complex binding |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0106140 | Molecular function | P-TEFb complex binding |
GO_0061628 | Molecular function | H3K27me3 modified histone binding |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
GO_0042809 | Molecular function | nuclear vitamin D receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TAF7 |
Protein name | Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55) Transcription initiation factor TFIID subunit 7 |
Synonyms | TAF2F TAFII55 |
Description | FUNCTION: The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription . TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) . The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 . TAF7 forms a promoter DNA binding subcomplex of TFIID, together with TAF1 and TAF2 . Part of a TFIID complex containing TAF10 (TFIID alpha) and a TFIID complex lacking TAF10 (TFIID beta) . . |
Accessions | ENST00000624761.2 Q15545 A0A096LPC3 ENST00000624761 ENST00000313368.8 |